Monosialotetrahexosylganglioside sodium injection

Monosialotetrahexosylganglioside can promote functional recovery of central nervous system damage caused by various reasons. The mechanism of action is to promote neuroplasticity (including the survival of nerve cells, axon growth and synaptic growth). Monosialotetrahexosylganglioside has a protective effect on secondary neurodegeneration after injury. Monosialotetrahexosylganglioside has a positive effect on cerebral hemodynamic parameters and brain edema caused by injury. Monosialotetrahexosylganglioside reduces nerve cell edema by improving the activity of cell membrane enzymes. Animal experiments show that monosialotetrahexosylganglioside can improve behavioral disorders caused by Parkinson's disease.

The main ingredient is monosialotetrahexosylganglioside sodium, which is a substance extracted from pig brain and has an effect on damage to nerve cell function.

This product is a colorless clear liquid.

Used to treat vascular or traumatic central nervous system injury; spinal cord injury; cerebral atrophy, cerebral infarction, cerebral hemorrhage, brain injury, cerebral palsy in children, neonatal hypoxic-ischemic encephalopathy, pediatric peripheral neuritis, Parkinson's disease, diabetic cranial neuropathy; diabetic peripheral neuropathy; peripheral neuropathy.

20-40 mg per day, once or divided into several intramuscular injections or slow intravenous drips as prescribed by the doctor. In the acute stage of the disease (especially acute trauma): 100 mg per day, intravenous drip; after 2-3 weeks, change to a maintenance dose of 20-40 mg per day, generally for 6 weeks. For Parkinson's disease, the first dose is 500-1000 mg, intravenous drip; from the second day onwards, 200 mg per day, subcutaneous, intramuscular or intravenous drip, generally used for 18 weeks.

A small number of patients developed a rash reaction after using this product and should be advised to stop using it.

Allergy to this product has been confirmed; hereditary lipid metabolism disorders (ganglioside storage diseases, such as familial Tay-Sachs disease, retinal degeneration).

Precautions for children: So far, no adverse reactions have been reported in children using this product. Precautions for pregnancy and lactation: According to literature, no adverse reactions have been observed in various animals using monosialotetrahexosylganglioside during pregnancy and lactation. Precautions for the elderly: So far, no adverse reactions have been reported in elderly patients using this product.

Not yet clear.

Store tightly closed at room temperature.

2ml:20mg

24 months.

Changchun Xiangtong Pharmaceutical Co., Ltd.

• Founded in:

  2003-12-12

• Address:

  No. 358, Tongyou Road, Industrial North District, Jiutai Economic Development Zone, Changchun

• Tax NO.:

  9122018175615056XD

• Registered Funds:

  16.88 million yuan

• Website:

  Log in to view

• Email:

  Log in to view